Dermatology / 30.11.2024

When you think about protecting your skin from harmful UV rays, you might imagine lounging on the beach or spending time outdoors. For some, it can be hard to remember the importance of doing so within a vehicle, too. Exposing your skin to harmful UV radiation can lead to premature aging and even increasing the risk of skin cancer. In this article, we'll delve into how sun exposure through car windows contributes to skin damage, and more importantly, how you can protect your skin while behind the wheel.

How sun exposure affects your skin while driving

When driving during daylight hours, you’re exposed to UV rays that can penetrate through your car windows. Many people believe that they are protected from the sun while in their vehicles, but the reality is that UV rays are still able to reach you. The sun emits two types of UV radiation that affect the skin: UVA and UVB rays. UVA ray exposure can cause premature aging, wrinkles, and fine lines. UVB rays, on the other hand, are responsible for sunburns and can also damage the skin’s DNA, leading to an increased risk of skin cancer. While most car windows block the majority of UVB rays, they don't block them all. On top of this, they often allow UVA rays to pass through. 74 percent of melanomas appear on the left side of the body of those in the United States, and this happens to be the side the driver's window is on. In fact, the risk is so significant that drivers may experience accelerated aging on their left side compared to the right. This type of sun exposure is often subtle and unnoticed but can have long-term consequences. (more…)
Dermatology / 21.11.2024

  If you've been dealing with acne-like bumps that just won’t go away, you might actually be dealing with something called fungal acne. Unlike regular acne caused by bacteria, fungal acne is a skin condition triggered by an overgrowth of yeast. Let’s dive into what fungal acne is, what causes it, and how to get rid of it effectively.  

What is Fungal Acne?

  Fungal acne, also known as Malassezia folliculitis, looks a lot like regular acne but has a different root cause. Instead of bacteria, fungal acne is caused by an overgrowth of yeast (a type of fungus) on the skin. Yeast naturally lives on our skin, but when too much is present, it can infect hair follicles and lead to itchy, small, uniform bumps that resemble pimples. One common misconception is that fungal acne looks like large, painful pimples. In reality, fungal acne typically appears as clusters of small, red or skin-colored bumps, often on the forehead, chest, and back. It’s usually itchy and can worsen in hot, humid environments where sweat and oil are present. So, if your usual acne treatments aren’t working, you might actually have fungal acne. (more…)
Dermatology / 07.11.2024

  acne-dermatology The acne problem affects millions of people in today's lifestyle. It is caused due to numerous reasons including hormone changes, poor lifestyle habits, and genetic problems. Effective management of this disorder often depends on finding the best dermatologist. The expertise and approach of a dermatologist greatly impact the treatment plan and outcomes for acne patients. From topical treatments to advanced therapies, a skilled dermatologist provides several treatment choices to help you have better skin and increase your confidence. Certifications Evaluating the credentials and experience is the initial aspect of choosing a dermatologist. A certified dermatologist undergoes significant training and must have expertise in identifying and treating skin diseases effectively. Evaluate their educational background, training, and any other qualifications pertinent to dermatology. Investigating the dermatologist's standing in the medical community can also help you understand their professional position and the quality of treatment they deliver. (more…)
Dermatology / 28.08.2024

As more people become aware of the potential health risks associated with synthetic chemicals, there is a growing interest in natural products. These alternatives offer a simple way to enhance your well-being by reducing exposure to harmful substances. Incorporating natural products into your daily routine doesn’t have to be complicated or expensive—it’s about making mindful choices that align with a healthier lifestyle. Starting Your Day with Natural Personal Care Products One of the easiest ways to begin incorporating natural products into your life is by updating your personal care routine. The products you use on your skin daily can significantly impact your overall health. Many conventional skincare products contain synthetic chemicals that can be harsh on your skin and may even lead to long-term health concerns. Switching to natural skincare products can help you avoid these risks while providing your skin with nourishing, organic ingredients. For example, you can replace your regular facial cleanser with one made from natural ingredients like aloe vera or chamomile, which are gentle and soothing. Moisturizers that use coconut oil or shea butter offer hydration without the need for synthetic additives. When it comes to sun protection, natural sunscreens with zinc oxide provide effective UV protection while being kinder to your skin and the environment. Your morning routine is another area where you can easily swap out conventional products for natural alternatives. Start by choosing a natural toothpaste free of artificial flavors and colors. Natural deodorants, which avoid aluminum and synthetic fragrances, can help you stay fresh without compromising your health. For body care, opt for natural body washes and soaps made with essential oils and plant-based ingredients. For those looking to switch to natural products, Melaleuca.com offers a wide range of options. Founded by Frank VanderSloot, who grew up on a farm and values natural, sustainable practices, Melaleuca has become a valuable source for wellness products. VanderSloot's commitment to quality and sustainability is reflected in the products offered on the site, making it easier for individuals to make healthier choices. (more…)
Dermatology / 20.08.2024

Dark spots, also known as hyperpigmentation, can be pretty distressing and are often caused by factors such as prolonged sun exposure, aging, hormonal changes, and inflammation. Melanin, the pigment responsible for skin tone, is overproduced in response to solar radiation and subsequently aggregates to form dark patches. Similarly, hormonal changes, particularly during pregnancy or due to oral contraceptives, can trigger melanin overproduction. Inflammatory responses, such as those from acne or eczema, also contribute to dark spots. One product to explore for reducing dark spots is Gundry MD Dark Spot Diminisher. You can learn more about Gundry MD Dark Spot Diminisher Reviews for insight into how it may help reduce dark spots. (more…)
Dermatology, Exercise - Fitness / 19.08.2024

Have you ever experienced the discomfort of scratched skin and wondered what activities might be causing it? Skin chafing is a common issue that can affect anyone, and understanding its triggers can help in prevention. Let’s explore the everyday activities that can lead to this irritating condition and how to manage them effectively.

Exercise and Physical Activity

Exercise is one of the most common culprits for chafed skin. Activities like running, cycling, and even walking can cause friction between the skin and clothing or between skin surfaces, leading to chafing. High-impact movements increase sweating, which further exacerbates the problem. Wearing moisture-wicking, well-fitting athletic wear can help reduce friction and keep the area dry. Applying anti-chafing balms or powders before exercising can also prevent irritation. Staying hydrated and choosing appropriate gear are essential to avoiding chafing during workouts. (more…)
Dermatology / 05.08.2024

MedicalResearch.com Interview with: Hannah CederHannah Ceder Department of Dermatology and Venereology Institute of Clinical Sciences, Sahlgrenska Academy University of Gothenburg Gothenburg, Sweden   MedicalResearch.com: What is the background for this study? Response: Many facial basal cell carcinomas (BCCs) are currently excised without prior biopsy, often resulting in incomplete surgical excisions. This practice is concerning because histopathologically high-risk BCCs have an increased risk of postoperative recurrence, necessitating a more meticulous surgical approach. For facial high-risk BCCs, Mohs micrographic surgery is the recommended treatment method. Given these challenges, there is a clear need for simple, preoperative methods to help physicians identify high-risk tumors. By improving preoperative assessment, these methods could enhance treatment planning, reduce incomplete excisions, and optimize the use of Mohs micrographic surgery for high-risk cases. (more…)
Dermatology / 02.08.2024

Editor's note:  Not all dark or discolored areas on the skin are benign.  Some may be cancerous or precancerous.  Please consult your dermatologist or  health care provider before beginning any depigmenting treatment and  follow up as the provider directs. Depigmenting treatments are not FDA approved and may have side effects, including allergic reactions and hyperpigmentation. They should not be used if pregnant, nursing or planning to become pregnant.  Please consult your provider for specific medical advice. What Are Dark Spots and Why Do They Appear? Hyperpigmentation, or "dark spots," are patches of skin that seem darker than the surrounding tissue. Although it can affect any region of the body, the face, arms, and hands are the most frequently affected areas. These spots form when cells known as melanocytes, which produce melanin, are overactive. The overproduction of melanin, the pigment responsible for skin color, leads to patches or spots that appear darker. Several factors contribute to the development of dark spots. One of the main causes is sun exposure since UV rays hasten the formation of melanin. Hyperpigmentation can also be brought on by hormonal changes, such as those brought on by birth control drugs or pregnancy. Additionally, skin injuries, acne, and other forms of inflammation can result in post-inflammatory hyperpigmentation. Using a dark spot remover can help mitigate these spots, but understanding their root causes is crucial for effective prevention and treatment. (more…)
Dermatology / 02.07.2024

Want to achieve that radiant, healthy glow? You’re in the right place. In this guide, we’re sharing five essential dermatology tips, straight from the experts, to help you get the skin of your dreams. From the best skincare routines to insider secrets on keeping your skin youthful and vibrant, we’ve got you covered. 

1. Sunscreen: Your Skin’s Best Friend

skincare_pexels-karolina-grabowska-4210657I can’t stress this enough - sunscreen is a must! Here’s why:
  • Protects against harmful UV rays
  • Prevents premature aging
  • Reduces risk of skin cancer
Dr. Shari Lipner from Weill Cornell Medicine says, “The single most important tip for healthy, glowing skin is to apply a broad spectrum sunscreen with SPF 30 or higher every single day”. Pro tip: Don’t forget often-missed spots like your ears, neck, and the backs of your hands! (more…)
Author Interviews, Dermatology, Melanoma, Race/Ethnic Diversity / 24.05.2024

MedicalResearch.com Interview with: Andrew F. Alexis, MD, MPH Vice-Chair for Diversity and Inclusion Department of Dermatology Dermatologist Center for Diverse Skin Complexions Weill Cornell Medicine – NY MedicalResearch.com: What are the main types of skin cancer?  Is the incidence changing? Response: The 3 main types of skin cancer are melanoma, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Skin cancer is the most common cancer in the United States1 and 1 in 5 Americans will develop skin cancer in their lifetime. (2) The overall incidence has changed as follows:Melanoma: Rates doubled over past 30 years from 1982 to 2011.3 It differs by age group. o Adolescents and adults age 30 and younger: incidence rate is declining o Older age groups (e.g. 80 and older): incidence rate is increasing • Squamous Cell Cancer: o Incidence increased 263% between 1976-1984 and 2000-20104 • Basal Cell Cancer: o Incidence increased 145% between 1976-1984 and 2000-20104 (more…)
Dermatology / 17.05.2024

Our skin is subject to a multitude of internal and external influences that can affect its thickness and texture over time. Factors such as aging, environmental aggressors, lifestyle choices, and genetics can contribute to the gradual thinning and deterioration of skin quality. However, the good news is that there are various approaches to address these concerns and promote the restoration of skin thickness and texture. In this article, we'll explore a few crucial factors that, according to research, play pivotal roles in this rejuvenation process.

The Proliferation and Migration of Skin Cells

skin-care-dermatologyAccording to the National Institutes of Health, at the core of skin thickness and texture restoration lies the process of cell proliferation and migration. The epidermis, the outermost layer of the skin, constantly undergoes renewal through a process known as epidermal turnover. Stem cells within the basal layer of the epidermis divide and differentiate into keratinocytes. These gradually migrate upward to the skin's surface, replacing old, damaged cells. According to Beyond CellCare, stem cell therapy differs from traditional treatments, which only target the symptoms of skin aging. By fostering cellular repair and renewal, it targets the fundamental mechanisms of aging. Furthermore, certain skincare ingredients and treatments, such as chemical exfoliants and professional procedures like microdermabrasion and chemical peels, can accelerate cell turnover. You’ll also find the use of exosome injection and similar therapy methods involving exosomes becoming popular in this regard. Exosomes facilitate skin cell proliferation and migration by transferring growth factors and signaling molecules. (Please note that exosomes are currently not approved by the Food and Drug Administration (FDA) to treat or diagnose any disease). (more…)
Aging, Author Interviews, Dermatology / 19.02.2024

MedicalResearch.com Interview with: Frank Wang MD William B. Taylor Endowed Professor of Clinical Dermatology Associate Professor, Dermatology Associate Chair for Education Assistant Program Director, Dermatology Residency Program University of Michigan Ann Arbor, Michigan MedicalResearch.com: What is the background for this study? How is the cross-linked hyaluronic acid obtained? Where was it injected? Response: As the skin undergoes photoaging due to chronic exposure to ultraviolet light, it loses dermal collagen, which in turn leads to wrinkling, lines, and loss of support. The loss of collagen is, in large part, due to reduced function of the skin’s collagen-producing cells, dermal fibroblasts. We wanted to investigate whether it was possible to reverse the decreased function of fibroblasts in photodamaged skin, by introducing a space-filling material into the dermis, injected CL-HA dermal filler. The CL-HA filler we used was donated to us for research purposes. We performed injections of CL-HA into the mid-dermis (as is normally done when injected into the face) of severely photoaged forearm skin of human participants over the age of 60. We then examined skin samples at various time points, including 1, 2, 3 and 4 weeks and 3, 6, 9, and 12 months post-injection. (more…)
Author Interviews, Dermatology, JAMA, Surgical Research / 16.11.2023

MedicalResearch.com Interview with: Peter C. Minneci, MD Chair of Surgery at Nemours Children’s Health Delaware Valley MedicalResearch.com: What is the background for this study?  Would you briefly explain the symptoms/course of pilonidal disease?  Response: Pilonidal disease is relatively common and affects up to 1% of the population starting in adolescence and up until young adulthood. Pilonidal disease occurs when cysts or sinuses form between the buttocks. It is believed to be an inflammatory reaction to hair or debris that gets caught in the crease of the buttocks. Risk factors for the condition include a sedentary lifestyle, hygiene and obesity. Pilonidal disease can be intermittent or chronic and recurs about 33% of the time, with 80% of recurrences taking place within a year of initial treatment. These recurrences contribute to a high degree of psychosocial stress in patients, who often miss school or sports and may avoid social activities. Pilonidal cysts may become infected, in which case patients must take antibiotics or undergo surgery.   Standard treatment for pilonidal disease involves removal of hair with razors or creams, as well as recommendations such as keeping the area clean. In recent years, some practitioners have begun using laser epilation as an additional strategy to prevent recurrence by providing more durable hair removal. However, it’s important to point out that this is not covered by insurance. In addition, as a provider, I have found that my patients that do have the means to pay often don’t comply with the number of sessions needed to fully remove the hair due to many different factors including pain and discomfort during the procedure.   (more…)
Author Interviews, Dermatology, Immunotherapy / 18.07.2023

MedicalResearch.com Interview with: Emma Guttman-Yassky, M.D., PhD, Lead investigator of this study Waldman Professor and System Chair Kimberly and Eric J. Waldman Department of Dermatology Icahn School of Medicine at Mount Sinai, NY   MedicalResearch.com: What is the background for this study? Response: The idea to test how spacing out treatment or even stopping it affects treatment responses once patients are well controlled. Lebrikizumab it is a potent biologic agent with a relatively long-lasting effect. (more…)
Author Interviews, Dermatology, Eli Lilly, Immunotherapy / 18.05.2023

MedicalResearch.com Interview with: Lotus Mallbris, MD PhD Dermatologist andSenior Vice President Global Immunology Development and Medical Affairs  Lilly   MedicalResearch.com: What is the background for this study?  Would you briefly describe what is meant by atopic dermatitis and types treated in this study? Response: First, this study specifically evaluated lebrikizumab, a novel, investigational, monoclonal antibody that selectively binds to interleukin 13 (IL-13) with high-affinity and high potency. Inflammation due to over-activation of the IL-13 pathway plays a central role in the pathogenesis of moderate-to-severe atopic dermatitis, commonly called eczema. This secondary analysis focused on patients treated with lebrikizumab from the 16-week induction periods of the ADvocate 1 and ADvocate 2 studies and the ADhere study. In the trials, we assessed the presence or absence of face or hand dermatitis in patients with moderate-to-severe atopic dermatitis. If present at baseline, at 16 weeks, clinicians assessed the change from baseline on a scale of cleared, improved, no change, or worsened. Only patients with face and hand dermatitis were evaluated as part of the analysis. (more…)
Author Interviews, Dermatology, JAMA / 15.05.2023

MedicalResearch.com Interview with: Matthew Zirwas, MD Founder, Bexley Dermatology Research Clinic Bexley, OH 43209 MedicalResearch.com: What is the background for this study? How does Roflumilast differ from other treatments for seb derm? Response: Seborrheic dermatitis affects up to 5% of the population globally and can have major impacts on quality of life. Treatment regimens are often complicated given the association of seborrheic dermatitis to hair bearing areas of the body, requiring multiple treatments for different parts of the body. Our phase 2 study aimed to understand the efficacy and safety of once-daily roflumilast foam 0.3% in adults with seborrheic dermatitis on their scalp, face and trunk. Roflumilast foam is a selective and highly potent phosphodiesterase (PDE) 4 inhibition that is being studied for a range of inflammatory skin conditions. (more…)
Author Interviews, Breast Cancer, Cancer Research, JAMA, MRSA, Radiation Therapy / 06.05.2023

MedicalResearch.com Interview with: Beth McLellan, M.D. Chief, Division of Dermatology Montefiore Medical Center Albert Einstein College of Medicine MedicalResearch.com: What is the background for this study? How is the decolonization initiated and maintained? Response: We were interested in exploring whether bacteria on the skin plays a role in radiation dermatitis like it does in other skin diseases that cause a breakdown in the skin barrier. We used a bacterial decolonization regimen that includes chlorhexidine 2% cleanser for the body and mupirocin 2% ointment to the inside of the nose for 5 consecutive days before starting radiation therapy and repeated for an additional 5 days every other week for the duration of radiation. (more…)
Author Interviews, Dermatology, Melanoma, USPSTF / 27.04.2023

MedicalResearch.com Interview with: John M. Ruiz, Ph.D Associate Professor of Clinical Psychology Department of Psychology University of Arizona Dr. Ruiz is the incoming editor-in-chief of the American Psychological Association (APA) journal, Health Psychology Dr. Ruiz joined the U.S. Preventive Services Task Force in January 2022     MedicalResearch.com: What is the background for this study? What are the main findings? Response: Skin cancer is the most common type of cancer in the United States, but it often does not cause serious complications or death. The Task Force’s recommendation on screening for skin cancer focuses on the effectiveness of visual skin exams for children and adults who do not have any symptoms. When reviewing the latest research, we found that there is currently not enough evidence to tell us whether or not screening people without signs or symptoms is beneficial. This is an I statement. (more…)
Author Interviews, Dermatology, Eli Lilly, NEJM / 26.03.2023

MedicalResearch.com Interview with: Jonathan Silverberg, MD, PHD, MPH Professor Director of Clinical Research Director of Patch Testing George Washington University School of Medicine and Health Sciences Washington, DC MedicalResearch.com: What is the background for this study? What are the main findings? Response: Lebrikizumab was previously shown to be safe and effective as a treatment for moderate-severe atopic dermatitis in a phase 2 study. These Phase 3 randomized placebo-controlled trials are the largest studies to date of lebrikizumab in AD. They showed that lebrikizumab was safe and highly effective for the treatment of moderate-severe atopic dermatitis. These studies will hopefully support the approval of lebrikizumab in the United States later this year. (more…)
Allergies, Author Interviews, Cancer Research, Dermatology, Melanoma / 17.03.2023

MedicalResearch.com Interview with: Jenni Komulainen University of Eastern Finland | UEF MedicalResearch.com: What is the background for this study? Response: The background for this study comes from the earlier findings that the skin cancer risk and atopic status have some connection, but the results have been inconsistent. The connection between atopy and skin cancers may be related to the stimulation of protective immune response or the predisposition to carcinogenesis through chronic inflammation. The aim of this study was to investigate if atopic disorders associate with skin cancers. (more…)
Allergies, Author Interviews, Dermatology / 09.03.2023

MedicalResearch.com Interview with: Nicholas Gulati, MD, PhD Director, Early Detection of Skin Cancer and Oncodermatology Clinic The Kimberly and Eric J. Waldman Department of Dermatology Mount Sinai Health System New York, New York MedicalResearch.com: What is the background for this study? What is dupilumab primarily used for? Response: Dupilumab is a monoclonal antibody that inhibits a specific part of the immune system known as Th2 cells, which are important in the development of various diseases including atopic dermatitis (eczema) and asthma. Therefore, dupilumab has become one of the major treatments for these conditions. Given the increasing use of this drug, it is important to understand the safety of it in terms of cancer development, as that is currently largely unknown. (more…)
Author Interviews, Dermatology, Lancet / 13.12.2022

MedicalResearch.com Interview with: Dr. Emma Guttman-Yassky, MD, PhD Waldman Professor and System Chair The Kimberly and Eric J. Waldman Department of Dermatology Director, Center of Excellence in Eczema Director, Laboratory of Inflammatory Skin Diseases Icahn School of Medicine at Mount Sinai MedicalResearch.com: What is the background for this study? What are the main findings? Response: The background for this study are studies that show that OX40 is a pathway that is upregulated in patients with atopic dermatitis (or eczema). OX40 is involved in activation of immune molecules associated with allergy and atopy, and also with formation of memory immune cells that are required for disease recurrence. The hypothesis to the study was that giving an OX40 antagonist will not only ameliorate the disease but perhaps have a remittive effect in that the disease will not come back. Indeed all drug doses were significantly effective at week 16, the primary endpoint compared to placebo and continued to improve towards week 36, the secondary endpoint. In addition, the responders to treatment maintained their responses for an additional 20 weeks, which is unusual, suggesting a potential for disease modification. (more…)
Aging, Author Interviews, Brigham & Women's - Harvard, Dermatology, Heart Disease, Herpes Viruses, Stroke / 23.11.2022

MedicalResearch.com Interview with:| Sharon G. Curhan, MD, ScM| Director, CHEARS: The Conservation of Hearing Study Channing Division of Network Medicine Department of Medicine Brigham and Women’s Hospital Harvard Medical School Boston, MA 02114 MedicalResearch.com: What is the background for this study? Response:       Herpes zoster, commonly known as “shingles,” is a viral infection that often causes a painful rash. Shingles can occur anywhere on the head or body. Shingles is caused by the varicella zoster virus (VZV), the same virus that causes chickenpox. After a person has chickenpox, the virus stays in their body for the rest of their life. Years and even decades later, the virus may reactivate as shingles. Almost all individuals age 50 years and older in the US have been infected with the varicella zoster virus and therefore they are at risk for shingles. About 1 in 3 people will develop shingles during their lifetime, and since age is a risk factor for shingles, this number may increase as the population ages. The risk is also higher among individuals of any age who are immunocompromised due to disease or treatment. A number of serious complications can occur when a person develops shingles, such as post-herpetic neuralgia (long-lasting pain), but there was limited information on whether there are other adverse long-term health implications of developing shingles. There is a growing body of evidence that links VZV, the virus that causes shingles, to vascular disease. VZV vasculopathy may cause damage to blood vessels and increase the risk of stroke or coronary heart disease. Although some previous studies showed a higher risk of stroke or heart attack around the time of the shingles infection, it was not known whether this higher risk persisted in the long term. Therefore, the question we aimed to address in this study was to investigate whether shingles is associated with higher long-term risk of stroke or coronary heart disease. To address this question, we conducted a prospective longitudinal study in 3 large US cohorts of >200,000 women and men, the Nurses’ Health Study (>79,000 women), the Nurses’ Health Study II (almost 94,000 women) and the Health Professionals Follow-Up Study (>31,000 men), without a prior history of stroke or coronary heart disease. We collected information on shingles, stroke and coronary heart disease on biennial questionnaires and confirmed the diagnoses with medical record review. We followed the participants for up to 16 years and evaluated whether those who had developed shingles were at higher risk for stroke or coronary heart disease years after the shingles episode. The outcomes we measured were incident stroke, incident coronary heart disease [defined as having a non-fatal or fatal myocardial infarction (heart attack) or a coronary revascularization procedure (CABG, coronary artery bypass graft or percutaneous transluminal coronary angioplasty)]. We also evaluated a combined outcome of cardiovascular disease, which included either stroke or coronary heart disease, whichever came first. (more…)
Author Interviews, Cancer Research, Dermatology, Race/Ethnic Diversity / 18.10.2022

MedicalResearch.com Interview with: Alexandra J. White, PhD, MSPH Stadtman Investigator Epidemiology Branch National Institute of Environmental Health Sciences National Institutes of Health Research Triangle Park, NC MedicalResearch.com: What is the background for this study? What is the chemical primarily used in hair straighteners? Response: Hair products such as dye and chemical straighteners contain several different chemicals that may act as carcinogens or endocrine disruptors and thus may be important for cancer risk. Straighteners in particular have been found to include chemicals such as phthalates, parabens, cyclosiloxanes and metals and may release formaldehyde when heated. Previous research has suggested that hair dye and chemical straighteners are related to other hormone-sensitive cancers such as breast and ovarian cancer, but no previous study has considered how they are related to uterine cancer risk. (more…)
Author Interviews, Dermatology, Immunotherapy, NEJM, University of Pittsburgh / 06.10.2022

MedicalResearch.com Interview with: Rohit Aggarwal, MD, MS Rheumatology, Professor of Medicine Medical Director, Arthritis and Autoimmunity Center Sub-Specialty Education Coordinator Division of Rheumatology Department of Medicine University of Pittsburgh MedicalResearch.com: What is the background for this study? Response: Dermatomyositis is a rare autoimmune inflammatory disease that affects muscles and skin, although muscular forms without skin symptoms and vice versa are also seen. The exact etiology of the disease is not known but is thought to be immune-mediated with many patients having highly specific autoantibodies. There is no cure for dermatomyositis, but several types of treatment have been successfully used in the last years including different kinds of immunosuppressants (e.g. steroids) and intravenous immune globulins (IVIG) to improve the patient’s condition. So far, none of these treatments was approved for use in dermatomyositis based on large, randomized, placebo-controlled trials. Their effectiveness was mainly deduced from clinical experience and from small clinical trials. The ProDERM study was the first large, pivotal, randomized placebo-controlled trial to evaluate the efficacy and safety of intravenous immune globulin (IVIG) in dermatomyositis patients. (more…)
Author Interviews, Cost of Health Care, Dermatology, JAMA / 08.09.2022

MedicalResearch.com Interview with: Jane M. Zhu, M.D., M.P.P., M.S.H.P. Assistant Professor of Medicine Division of General Internal Medicine and Geriatrics School of Medicine Oregon Health & Science University Portland, Oregon MedicalResearch.com: What is the background for this study? Response: Private equity (PE) acquisitions of physician practices are accelerating across many specialties, but there is still little robust evidence on the effects of these acquisitions. Concerns about PE involvement is predicated on the fact that these firms expect high annual returns, which require either reducing costs or increasing revenue, or both. Using PE acquisition data from 2016-2020, linked to commercial claims data, we sought to understand what common mechanisms of revenue generation were being adopted after private equity acquisition of physician practices. (more…)